Reuters logo
BRIEF-Merck says FDA approves Keytruda(pembrolizumab) for previously treated patients
September 22, 2017 / 7:49 PM / in a month

BRIEF-Merck says FDA approves Keytruda(pembrolizumab) for previously treated patients

Sept 22 (Reuters) - Merck & Co Inc

* Fda approves Merck’s keytruda® (pembrolizumab) for previously treated patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction cancer whose tumors express pd-l1 (cps greater than or equal to 1)

* FDA ‍approves co’s keytruda (pembrolizumab) for previously treated patients

* Approval for Keytruda was based on data from trial Keynote-059​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below